A Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid Cancer
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine if AMG 706 will have clinically meaningful
anti-tumor activity in subjects with locally advanced or metastatic thyroid cancer who are
not candidates for radioactive iodine therapy or local therapies.